NRGEX | QISGX | NRGEX / QISGX | |
Total Expense Ratio | 0.03 | 0.89 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 1.13 | 61% |
Fund Existence | 4 years | 20 years | - |
Gain YTD | -3.342 | 14.621 | -23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 546M | 1,596% |
Annual Yield % from dividends | 0.54 | 0.00 | - |
Returns for 1 year | -9.46 | 14.26 | -66% |
Returns for 3 years | 8.17 | 58.41 | 14% |
Returns for 5 years | N/A | 19.10 | - |
Returns for 10 years | N/A | 58.10 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
TICSX | 7.39 | 0.04 | +0.54% |
Touchstone Small Company Instl | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |